Brophy Patrick D., Charlton Jennifer R., Bryan Carmody J., Reidy Kimberly J., Harshman Lyndsay, Segar Jeffrey, Askenazi David, Shoham David, Bagby Susan P.
University of Iowa Stead Family Children’s Hospital, Pediatric Nephrology, Iowa City, IA, USA
Department of Pediatrics, Division of Nephrology, University of Virginia, Charlottesville, VA, USA
Chronic kidney disease (CKD) reflects life events that range from maternal-fetal influences to geriatric exposures. The global direct and indirect costs of CKD are high and include maternal-neonatal hospitalization and treatment, acute kidney injury, dialysis and transplant, missed work, and medications, to name a few. The impact of poor diet, adverse childhood experiences, medication use, and failure to follow consistent public health standards are increasingly appreciated as key influences in the development of CKD. Socioeconomic factors can significantly influence the timing and phenotypic expression in people at risk for developing CKD, although more research is needed to understand these mechanisms. In general, biomedicine has been focused on treating well-established CKD morbidity. This strategy has been short sighted and costly. A more cost-effective approach would focus on early life interventions that hold the potential for mitigating CKD risk and its sequelae. This chapter applies the life course health development principles to review determinants and pathways for CKD evolution and identifies of the gaps in our knowledgebase. We also discuss several research strategies for evaluating the life course health development of CKD.
慢性肾脏病(CKD)反映了从母婴影响到老年暴露等一系列生活事件。CKD的全球直接和间接成本高昂,包括母婴住院和治疗、急性肾损伤、透析和移植、误工以及药物治疗等。不良饮食、儿童期不良经历、药物使用以及未能遵循一致的公共卫生标准对CKD发展的影响日益被视为关键因素。社会经济因素可显著影响CKD高危人群发病的时间和表型表达,尽管仍需更多研究来了解这些机制。总体而言,生物医学一直专注于治疗已确诊的CKD发病率。这种策略目光短浅且成本高昂。一种更具成本效益的方法将侧重于早期生活干预,这有可能降低CKD风险及其后遗症。本章应用生命历程健康发展原则来回顾CKD演变的决定因素和途径,并找出我们知识库中的差距。我们还讨论了几种评估CKD生命历程健康发展的研究策略。